Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Nature Biotechnology
|
May 20, 2006
IBM opens the IP vaults
George S Mack
Journal of the National Cancer Institute
|
February 2, 2006
Clinical trials going to the dogs: canine program to study tumor treatment, biology
George S Mack
Nature Biotechnology
|
September 10, 2008
Pharmas partner in venture seeking drug discovery tools
George S Mack
Nature Biotechnology
|
July 10, 2008
Profile: Julian Davies
George S Mack
Nature Medicine
|
May 6, 2006
Trial set to test how stem cells heal a broken heart
George S Mack
Nature Medicine
|
October 8, 2005
Cancer researchers usher in dog days of medicine
George S Mack
Nature Biotechnology
|
February 11, 2009
FDA holds court on post hoc data linking KRAS status to drug response
George S Mack
Nature Biotechnology
|
October 10, 2009
Expanded access rules pose quandary for drug developers
George S Mack
Nature Biotechnology
|
February 9, 2011
ReNeuron and StemCells get green light for neural stem cell trials
George S Mack
Nature Biotechnology
|
August 3, 2005
Early-stage exits: sometimes less is more
George S Mack
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Nature Biotechnology
|
May 20, 2006
IBM opens the IP vaults
George S Mack
Journal of the National Cancer Institute
|
February 2, 2006
Clinical trials going to the dogs: canine program to study tumor treatment, biology
George S Mack
Nature Biotechnology
|
September 10, 2008
Pharmas partner in venture seeking drug discovery tools
George S Mack
Nature Biotechnology
|
July 10, 2008
Profile: Julian Davies
George S Mack
Nature Medicine
|
May 6, 2006
Trial set to test how stem cells heal a broken heart
George S Mack
Nature Medicine
|
October 8, 2005
Cancer researchers usher in dog days of medicine
George S Mack
Nature Biotechnology
|
February 11, 2009
FDA holds court on post hoc data linking KRAS status to drug response
George S Mack
Nature Biotechnology
|
October 10, 2009
Expanded access rules pose quandary for drug developers
George S Mack
Nature Biotechnology
|
February 9, 2011
ReNeuron and StemCells get green light for neural stem cell trials
George S Mack
Nature Biotechnology
|
August 3, 2005
Early-stage exits: sometimes less is more
George S Mack
Page
of 3